International Journal of Clinical Pharmacy

, Volume 36, Issue 3, pp 604–614 | Cite as

Provision of smoking cessation services in Australian community pharmacies: a simulated patient study

  • Maya SabaEmail author
  • Jessica Diep
  • Renee Bittoun
  • Bandana Saini
Research Article


Background With the rising interest in expanding pharmacists’ role in smoking cessation, it is pertinent that community pharmacists be equipped with up-to-date knowledge and competence to provide optimal therapeutic services that meet the demands of various presenting subsets of smokers. Objective To investigate and evaluate responses to requests of quitting smoking from ‘high risk’ smokers seeking assistance and treatment within the pharmacy venue. Setting Community pharmacies located within Sydney greater metropolitan area, New South Wales, Australia. Method A simulated patient methodology was utilised. Two scenarios were developed and enacted by two trained simulated patients in 100 randomly selected pharmacies. Scenario 1 involved a 28-year-old pregnant female who presents with a request for help in quitting smoking. Scenario 2 involved a 22-year-old female requesting a quit smoking product for her 55-year-old father who has cardiovascular problems. A standardised scoring key was designed to assess the performance of pharmacists during each encounter. Main outcome measure The primary outcome measure was the supply/non-supply of nicotine replacement products and the corresponding provision of counselling and advice to facilitate smoking cessation. Results A product(s) was supplied in 42 % of the 100 encounters, while a product was adequately suggested pending doctor’s referral in 45 %. In 13 % of the cases, a product was not supplied based on inappropriate notions of nicotine replacement therapy not being safe in the presented scenario. Pharmacists performed better in dispensing scores (counselling about product use) as compared to pre-dispensing scores (eliciting patient history). ANOVA followed by regression analysis indicated that the estimated age and gender of the pharmacist/staff were significant predictors affecting total scores. Conclusion Whilst pharmacists’ counselling about smoking cessation aids seems satisfactory, further education is required to improve practice standards in terms of matching a patient’s history and smoking status to an appropriate product.


Australia Counselling Nicotine replacement therapy Pharmacist Simulated patient Smoking cessation 






Conflicts of interest

The authors have no conflicts of interest to declare.

Supplementary material

11096_2014_9944_MOESM1_ESM.docx (28 kb)
(DOCX 38 kb)


  1. 1.
    Centers for Disease Control and Prevention. Smoking and tobacco use: fast facts. 2013 [cited 30 Oct 2013].
  2. 2.
    World Health Organization. WHO framework convention on tobacco control. 2003 [cited 31 Oct 2013].
  3. 3.
    Cancer Council Victoria. Smokefree generation within reach after high court upholds plain packaging. Media Release. 2012 [cited 31 Oct 2013].
  4. 4.
    Rigotti NA, Clair C, Munafò MR, Stead LF. Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev. 2012;5:CD001837.PubMedGoogle Scholar
  5. 5.
    World Health Organization. WHO report on the global tobacco epidemic-enforcing bans on tobacco advertising, promotion and sponsorship. 2013 [cited 25 July 2013].
  6. 6.
    American Cancer Society. CDC: adult smoking rates remain steady. 2012 [cited 25 July 2013].
  7. 7.
    Chapman S, MacKenzie R. There’s nothing that succeeds like failure: discerning the woods from the trees in smoking cessation debates. Nicotine Tob Res. 2013;15(3):750–1.PubMedCrossRefGoogle Scholar
  8. 8.
    ICD10 Data. Nicotine dependence F17. ICD-10-CM Coding reference. 2013 [cited 9 Nov 2013].
  9. 9.
    Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2012;11:CD000146.PubMedGoogle Scholar
  10. 10.
    Thomas D. Smoking and cardiovascular diseases. Rev Prat. 2012;62(3):339–43.PubMedGoogle Scholar
  11. 11.
    Osadchy A, Kazmin A, Koren G. Nicotine replacement therapy during pregnancy: recommended or not recommended? J Obstet Gynaecol Can. 2009;31(8):744–7.PubMedGoogle Scholar
  12. 12.
    Coleman T, Chamberlain C, Davey MA, Cooper SE, Leonardi-Bee J. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev. 2012;9:CD010078.PubMedGoogle Scholar
  13. 13.
    Brose LS, McEwen A, West R. Association between nicotine replacement therapy use in pregnancy and smoking cessation. Drug Alcohol Depend. 2013;132(3):660–4.PubMedCrossRefGoogle Scholar
  14. 14.
    Dent LA, Harris KJ, Noonan CW. Tobacco interventions delivered by pharmacists: a summary and systematic review. Pharmacotherapy. 2007;27(7):1040–51.PubMedCrossRefGoogle Scholar
  15. 15.
    Sinclair HK, Bond CM, Stead LF. Community pharmacy personnel interventions for smoking cessation. Cochrane Database Syst Rev. 2004;1:CD003698.PubMedGoogle Scholar
  16. 16.
    Blenkinsopp A, Anderson C, Armstrong M. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. J Public Health Med. 2003;25(2):144–53.PubMedCrossRefGoogle Scholar
  17. 17.
    Roughead L, Semple S, Vitry A. The value of pharmacist professional services in the community setting: a systematic review of the literature 1990–2002. Adelaide, South Australia: Quality Use of Medicines and Pharmacy Research Centre, University of South Australia; 2003 [cited 31 Oct 2013].
  18. 18.
    Australian Bureau of Statistics. Tobacco smoking. 2012 [cited 1 Nov 2013].
  19. 19.
    Germain D, Durkin S, Scollo M, Wakefield M. The long-term decline of adult tobacco use in Victoria: changes in smoking initiation and quitting over a quarter of a century of tobacco control. Aust N Z J Public Health. 2012;36(1):17–23.PubMedCrossRefGoogle Scholar
  20. 20.
    Ferguson SG, Shiffman S, Gitchell JG. Nicotine replacement therapies: patient safety and persistence. Patient Relat Outcome Meas. 2011;2:111–7.PubMedCentralPubMedCrossRefGoogle Scholar
  21. 21.
    Paul CL, Walsh RA, Girgis A. Nicotine replacement therapy products over the counter: real-life use in the Australian community. Aust N Z J Public Health. 2003;27(5):491–5.PubMedCrossRefGoogle Scholar
  22. 22.
    Chiang P, Chapman S. Do pharmacy staff recommend evidenced-based smoking cessation products? A pseudo patron study. J Clin Pharm Ther. 2006;31(3):205–9.PubMedCrossRefGoogle Scholar
  23. 23.
    Saba M, Bittoun R, Kritikos V, Saini B. Smoking cessation in community pharmacy practice-a clinical information needs analysis. SpringerPlus. 2013;2:449.PubMedCentralPubMedCrossRefGoogle Scholar
  24. 24.
    Zwar N, Richmond R, Borland R et al. Supporting smoking cessation: a guide for health professionals. Melbourne: The Royal Australian College of General Practitioners; 2011 [cited 1 Nov 2013].
  25. 25.
    Australian Government. National Tobacco Campaign 2013—more targeted approach campaign. 2013 [cited 2 Nov 2013].
  26. 26.
    ABC News. Heart attack victims continue to smoke despite warnings. 2013 [cited 2 Nov 2013].
  27. 27.
    Xu T, de Almeida Neto AC, Moles RJ. A systematic review of simulated-patient methods used in community pharmacy to assess the provision of non-prescription medicines. Int J Pharm Pract. 2012;20(5):307–19.PubMedCrossRefGoogle Scholar
  28. 28.
    Chong WW, Aslani P, Chen TF. Pharmacist-patient communication on use of antidepressants: a simulated patient study in community pharmacy. Res Social Adm Pharm. 2014;10(2):419–37.Google Scholar
  29. 29.
    Kippist C, Wong K, Bartlett D, Saini B. How do pharmacists respond to complaints of acute insomnia? A simulated patient study. Int J Clin Pharm. 2011;33(2):237–45.PubMedCrossRefGoogle Scholar
  30. 30.
    Queddeng K, Chaar B, Williams K. Emergency contraception in Australian community pharmacies: a simulated patient study. Contraception. 2011;83(2):176–82.PubMedCrossRefGoogle Scholar
  31. 31.
    Schneider CR, Everett AW, Geelhoed E, Kendall PA, Murray K, Garnett P, Salama M, Clifford RM. Provision of primary care to patients with chronic cough in the community pharmacy setting. Ann Pharmacother. 2011;45(3):402–8.PubMedCrossRefGoogle Scholar
  32. 32.
    Saengcharoen W, Lerkiatbundit S. Migraine management in community pharmacies: practice patterns and knowledge of pharmacy personnel in Thailand. Headache. 2013;53(9):1451–63.PubMedGoogle Scholar
  33. 33.
    Mesquita AR, de Oliveira Sá DA, Santos AP, de Almeida Neto A, Lyra DP Jr. Assessment of pharmacist’s recommendation of non-prescription medicines in Brazil: a simulated patient study. Int J Clin Pharm. 2013;35(4):647–55.PubMedCrossRefGoogle Scholar
  34. 34.
    Horvat N, Koder M, Kos M. Using the simulated patient methodology to assess paracetamol-related counselling for headache. PLoS ONE. 2012;7(12):e52510.PubMedCentralPubMedCrossRefGoogle Scholar
  35. 35.
    Puspitasari HP, Faturrohmah A, Hermansyah A. Do Indonesian community pharmacy workers respond to antibiotics requests appropriately? Trop Med Int Health. 2011;16(7):840–6.PubMedCrossRefGoogle Scholar
  36. 36.
    Weiss MC, Booth A, Jones B, Ramjeet S, Wong E. Use of simulated patients to assess the clinical and communication skills of community pharmacists. Pharm World Sci. 2010;32(3):353–61.PubMedCrossRefGoogle Scholar
  37. 37.
    Rhodes KV, Miller FG. Simulated patient studies: an ethical analysis. Milbank Q. 2012;90(4):706–24.PubMedCentralPubMedCrossRefGoogle Scholar
  38. 38.
    Pharmaceutical Society of Australia. Provision of non-prescription medicines and therapeutic devices. Professional Practice Standards, 4th ed. 2010 [cited 10 Oct 2013].
  39. 39.
    Puumalainen II, Peura SH, Kansanaho HM, Benrimoj CSI, Airaksinen MSA. Progress in patient counselling practices in Finnish community pharmacies. Int J Pharm Pract. 2005;13:149–56.CrossRefGoogle Scholar
  40. 40.
    Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict. 1989;84(7):791–9.PubMedCrossRefGoogle Scholar
  41. 41.
    VanVoorhis CRW, Morgan BL. Understanding power and rules of thumb for determining sample sizes. Tutor Quant Methods Psychol. 2007;3(2):43–50.Google Scholar
  42. 42.
    Chong WW, Aslani P, Chen TF. Adherence to antidepressant medications: an evaluation of community pharmacists’ counseling practices. Patient Prefer Adherence. 2013;7:813–25.PubMedCentralPubMedCrossRefGoogle Scholar
  43. 43.
    Lawrence M. The changing face of pharmacies. Zuellig Pharma. 2013 [cited 7 Nov 2013].
  44. 44.
    Benrimoj SI, Werner JB, Raffaele C, Roberts AS, Costa FA. Monitoring quality standards in the provision of non-prescription medicines from Australian Community Pharmacies: results of a national programme. Qual Saf Health Care. 2007;16(5):354–8.PubMedCentralPubMedCrossRefGoogle Scholar
  45. 45.
    Pharmaceutical Society of Australia. National Competency Standards Framework for Pharmacists in Australia. 2010 [cited 25 Oct 2013].
  46. 46.
    Sando KR, Elliott J, Stanton ML, Doty R. An educational tool for teaching medication history taking to pharmacy students. Am J Pharm Educ. 2013;77(5):105.PubMedCentralPubMedCrossRefGoogle Scholar
  47. 47.
    Austin Z, Tsuyuki RT. Are pharmacists the ultimate barrier to pharmacy practice change? Can Pharm J. 2010;143(1):37–42.Google Scholar
  48. 48.
    Rieck A, Pettigrew S. How physician and community pharmacist perceptions of the community pharmacist role in Australian primary care influence the quality of collaborative chronic disease management. Qual Prim Care. 2013;21(2):105–11.PubMedGoogle Scholar
  49. 49.
    Roberts AS, Benrimoj SI, Chen TF, Williams KA, Hopp TR, Aslani P. Understanding practice change in community pharmacy: a qualitative study in Australia. Res Social Adm Pharm. 2005;1(4):546–64.PubMedCrossRefGoogle Scholar
  50. 50.
    Tonna AP, Stewart D, West B, McCaig D. Pharmacist prescribing in the UK—a literature review of current practice and research. J Clin Pharm Ther. 2007;32(6):545–56.PubMedCrossRefGoogle Scholar
  51. 51.
    Coleman T. Recommendations for the use of pharmacological smoking cessation strategies in pregnant women. CNS Drugs. 2007;21(12):983–93.PubMedCrossRefGoogle Scholar
  52. 52.
    Svarstad BL, Bultman DC, Mount JK. Patient counseling provided in community pharmacies: effects of state regulation, pharmacist age, and busyness. J Am Pharm Assoc. 2004;44(1):22–9.CrossRefGoogle Scholar
  53. 53.
    Chua SS, Ramachandran CD, Paraidathathu TT. Response of community pharmacists to the presentation of back pain: a simulated patient study. Int J Pharm Pract. 2006;14(3):171–8.CrossRefGoogle Scholar

Copyright information

© Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie 2014

Authors and Affiliations

  • Maya Saba
    • 1
    Email author
  • Jessica Diep
    • 1
  • Renee Bittoun
    • 2
  • Bandana Saini
    • 1
  1. 1.Faculty of PharmacyThe University of SydneySydneyAustralia
  2. 2.Brain and Mind Research InstituteThe University of SydneySydneyAustralia

Personalised recommendations